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ABSTRACT  The cell substrate attachment (CSAT) antigen is an integral membrane glycoprotein 
complex  that  participates  in  the  adhesion  of  cells to  extracellular  molecules.  The  CSAT 
monoclonal antibody, directed against this complex, inhibited adhesion of cardiac and tendon 
fibroblasts and ske[etat myoblasts to both laminin and fibronectin,  thus implicating the CSAT 
antigen in adhesion to these extracellular molecules. 
Equilibrium gel filtration was used to explore the hypothesis that the CSAT antigen functions 
as a cell surface receptor  for  both  laminin  and fibronectin.  In this technique,  designed for 
rapidly  exchanging equilibria,  the gel filtration  column  is pre-equilibrated  with extracellular 
ligand to ensure receptor occupancy during its journey through the column. Both laminin and 
fibronectin  formed  complexes with  the  CSAT antigen. The  association with  laminin was 
inhibited  by  the  CSAT monoclonal  antibody;  the  associations with  both  fibronectin  and 
laminin were inhibited by synthetic peptides containing the fibronectin  cell-binding sequence. 
Estimates of the  dissociation  constants by  equilibrium  gel  filtration  agree well  with  those 
available  from  other  measurements. This suggests that  these associations are  biologically 
significant. SDS PAGE showed that all three glycoproteins comprising the CSAT antigen were 
present in the antigen-ligand  complexes. Gel filtration  and velocity sedimentation were used 
to show that the three bands comprise an oligomeric complex, which provides an explanation 
for their functional association. The inhibition of adhesion by the CSAT monoclonal antibody 
and the association of the purified antigen with extracellular ligands are interpreted as strongly 
implicating  the CSAT antigen as a receptor for both fibronectin  and laminin and perhaps for 
other extracellular molecules as well. 
The interaction of cells with components of the extracellular 
matrix plays a  major role in determining cell  morphology, 
cell migration, and tissue  maintenance (1). Putative sites of 
cell-matrix contact have been  identified  and studied  using 
various microscopic techniques. In fibroblasts  they occur in 
regions where the cellular cytoskeleton and associated  com- 
ponents interact with the cell  surface (2-4).  Integral mem- 
brane proteins are hypothesized to be present in these  sites 
and to serve as transmembrane links connecting cytoskeletal 
and the extracellular  matrix components. These transmem- 
brane proteins would then serve as dual receptors for cyto- 
skeletal and extracellular  matrix components. 
We  have  identified  a  candidate  for  such  a  cell  surface 
molecule using an adhesion and morphology perturbing cell 
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substrate  attachment (CSAT) ~  monoclonal antibody (5). This 
monoclonal antibody alters the adhesion of several different 
cell types in culture.  The nature and degree of perturbation 
by the CSAT monoclonal antibody is characteristic  for differ- 
ent cell types (6). The antigen to which the antibody is directed 
has been  purified by immunoaffinity chromatography and 
partially  characterized (7). It is a  complex of three distinct 
integral  membrane glycoproteins that migrate in the molec- 
Abbreviations used in this paper: CMF-PBS, calcium- and magne- 
sium-free phosphate-buffered  saline; CSAT,  cell substrate attachment; 
DME, Dulbecco's  modified  Eagle's  medium; RCF, relative centrifugal 
force; TNC, 0.01 M Tris-acetic acid, 0.5% Nonidet P-40, 0.5 mM 
CaC12, 0.15 M NaC1, pH 8.0. 
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fibroblasts has been localized using immunofluorescence to 
regions along portions of stress fibers and in regions surround- 
ing focal contacts as identified by vinculin staining (8). Similar 
observations and conclusions have been made using another 
monoclonal antibody, JG-22, which was isolated independ- 
ently and is directed against the same protein complex (9- 
12). 
In this  paper,  we  explore  further  the  role  of the  CSAT 
antigen  in  adhesion  to  extracellular  matrix  molecules  by 
addressing three issues: (a) the extracellular matrix molecules 
with which adhesions involving the CSAT antigen interact; 
(b) the role of the CSAT antigen in adhesion to these extra- 
cellular matrix molecules; and (c) the origin of the character- 
istic  responses  of different  cells  to  the  CSAT  monoclonal 
antibody.  We  have used  three  cell  types in  these  studies- 
tendon fibroblasts, skeletal myoblasts, and cardiac fibroblasts. 
Cell cultures of the first two cell types are responsive to the 
CSAT monoclonal antibody, whereas cultures of the cardiac 
fibroblasts are not (6). The adhesion to two well characterized 
and readily available extracellular molecules, fibronectin and 
laminin,  were  studied  (13-17).  We  report  that  the  CSAT 
antigen participates in adhesion to both fibronectin and lam- 
inin. We also report that the purified antigen is an oligomeric 
complex that binds to both of these extracellular molecules. 
These data along with previous observations provides very 
strong evidence that the CSAT antigen functions as a receptor 
for both fibronectin and laminin and perhaps for other extra- 
cellular matrix molecules as well.  They are also consistent 
with the suggestion that the antigen functions as an extracel- 
lular matrix-cytoskeleton transmembrane link. 
MATERIALS  AND  METHODS 
Avian Cell Cultures:  Skeletal myoblasts were explanted, dissociated, 
and cultured as described previously (6). The dissociated pectoral muscle cells 
were plated onto Falcon tissue culture dishes (Falcon Labware,  Oxnard, CA) 
coated with 0.1% gelatin (BBL Microbiology Systems, Cockeysville, MD) at a 
density of 3.5-4.5  ×  l0  ~ cells/35-mm dish. The cells were grown in calcium- 
free Dulbecco's modified Eagle's medium (DME) containing 10% horse serum, 
2% chick embryo extract or 40 ug/ml conalbumin (Sigma Chemical Co.,  St. 
Louis, MO), and 0.2-0.3 mM EGTA to prevent fusion. 
Tendon fibroblasts were obtained from  I5-18-d embryos as described pre- 
viously (6). The isolated tendons were incubated for 40 rain at 37°C in 1 mg/ 
ml collagenase (CLS II, Worthington Biochemicals,  Freehold,  NJ) and 0.25% 
trypsin (Gibco, Grand Island, NY) in calcium- and magnesium-free  phosphate- 
buffered  saline (CMF-PBS)  followed  by pipetting. The dissociated cells were 
washed and plated onto 100-mm Falcon tissue culture dishes (Falcon Labware) 
at a density of 2-5 x  105 cells/plate. The ceils were passaged at least two times, 
seeded in tissue culture dishes at a density of 2-5 x  10  ~ cells/plate, and grown 
in DME containing 10% fetal calf serum. Cells passaged more than 10 times 
were discarded. 
Cardiac fibroblasts were isolated from 14-d embryo ventricles  after dissocia- 
tion by 2.5  mg/ml collagenase and pipetting (6). The cells were plated onto 
Falcon tissue culture dishes (3 ventricles  per 100-ram dish) in DME containing 
10% fetal calf serum. After 1 h the nonadherent cells were decanted and fresh 
medium added.  The cells were pass,aged at least three times before use, seeded 
at a density of 2-5 x  l0  ~ ceUs/100-mm plate, and grown in DME containing 
10% fetal calf serum. Cells passaged more than I0 times were discarded. 
Cell Substratum Adhesion Assays:  2-d cultures prepared as de- 
scribed above at a density of 75-85% of confluency were washed twice with 
CMF-PBS containing  0.02% EDTA and incubated for 5 min (tendon fibrohlasts 
and skeletal myoblasts) or  30  min (cardiac fihroblasts)  in 0.02%  EDTA  in 
CMF-HEPES Hanks' buffered  balanced salt solution. The rounded cells were 
harvested by gentle pipetting using a fire polished Pasteur pipette and centri- 
fuged at 160 g for 3-4 min. The cells were resuspended into DME containing 
2% bovine serum albumin (BSA; Sigma Chemical Co.) and counted. Viability 
was estimated using 0.4% trypan blue.  1.25 x  l0  ~  cells/well  were added to each 
laminin or fibronectin-coated Linbro tissue culture or nontissue culture mul- 
tiwell plate (No. 76-000-04 or 76-000-05, Flow Laboratories,  McLean,  VA) and 
the final volume brought to 0.5 ml. The CSAT monoclonal  antibody was added 
either at the time of plating or after cell adhesion and spreading (30-180 min). 
For experiments using fibronectin peptides,  spot cultures of 10 ~tl containing 
3-6 x  10  ~ cells/ml were plated onto multiwells coated as above.  These  were 
gently flooded with 0.5 ml of medium for optical observation. 
For  trypsinization experiments cultures were  incubated with  25  ~*g/ml 
cycloheximide  (Sigma Chemical Co.) for 2 h before harvest; cycloheximide  was 
present in all subsequent solutions. (This procedure was also used for cyclohex- 
imide-treated  cells.) The cells  were washed two times in HEPES Hanks' buffer, 
and 4 ml of trypsin (type Ill; Sigma Chemical Co.) at a concentration of I mr/ 
ml in HEPES  Hanks' was added.  The cultures were incubated for 30 min at 
37°C. The cells  were then harvested by pipetting, 8 mg soybean trypsin inhibitor 
(type Ils, Sigma Chemical Co.) added, and the cells centrifuged for 3-4 min at 
180 g. The cells were washed in DME containing  soybean trypsin inhibitor  and 
finally resuspended  in DME containing 2% BSA for assays described above. 
A  more  quantitative assay of cell  substratum adhesion,  based  on  that 
described  by McClay et al.  (18),  was also used.  1.8  ml of a  cell suspension 
containing 9 x  104 cells/ml in DME with 2% BSA and 20 mM HEPES were 
aliquoted into Linbro tissue culture vinyl or nontissue culture multiwells  (No. 
76-000-04 and No. 76-000-05, Flow Laboratories).  The wells were sealed with 
plastic cell cover sheets (No. 76-401-05,  Flow Laboratories)  and centrifuged at 
66 g  for  10 rain at 4"C. The cells were  then incubated for 30 min (tendon 
fibroblasts and skeletal myoblasts) or 45 min (cardiac fibroblasts) at 37°C. The 
wells were inverted and centrifuged again at t 3 g or 66 g or just allowed to sit 
inverted (1 g) for I0 rain at 4"C. The cover sheets were cut open with a scalpel, 
and the supernatant gently decanted.  The wells were then placed on a warm 
plate at 37"C, and the adherent cells were removed by trypsinization  and then 
counted. The data are expressed  as a  percent of the total number of cells 
initially  added to the well. 
Wells were coated either with laminin, derived from an Englebreth  Holm 
Swarm (EHS)  sarcoma (Bethesda  Research  Laboratories,  Gaithersberg,  MD; 
Collaborative  Research, Waltham MA; or a gift  from Hynda Kleinman), human 
plasma fibronectin (Collaborative Research;  Bethesda  Research  Laboratories; 
or a gift from Jeremy Paul and Richard Hynes), poly-L-lysine (22,000 tool wt; 
Sigma Chemical Co.), type I collagen  (Collaborative  Research), type IV collagen 
(a gift of Hynda Kleinman), or vitronectin (Calbiocbem-Behring  Corp.,  La 
Julia, CA).  l0 #l from a stock solution of laminin or fibronectin at a concen- 
tration of I mg/ml in CAPS buffer (cyclohexylaminopropane  sulfonic acid, pH 
I l; Sigma Chemical Co.) was added to each well and diluted to a total volume 
of 0.5  ml with CMF-PBS.  In later experiments the laminin stock was in  l0 
mM Tris-HCl buffer, pH 7.2. The wells were incubated for 2 h, or overnight at 
37"C, aspirated, and washed twice with CMF-PBS. Multiwells  were coated with 
other substrates by adding appropriate stock solutions to the wells, incubating 
for 2-4 h at 37*C, and rinsing with medium or PBS. The poly-L-lysine was 
used at a concentration of 18 ~tg/well from a  stock solution at 35 ug/ml in 
borate buffer pH 8.0; types I and IV collagen were used at a concentration of 
12  ~g/well from  a  stock solution at 0.5  mg/ml in 0.1  N  acetic acid; and 
vitronectin was used at a concentration of 2.5-l0 ug/well from a stock solution 
at 1 mg/ml in PBS. The collagen solutions were first spread evenly and then 
allowed to dry on the wells. 
Antigen Isolation:  [3SS]Methionine labeling of cell cultures and the 
subsequent CSAT antigen purification and analysis by SDS PAGE were per- 
formed as described previously except that the acetone precipitation step was 
omitted (5-7).  Unlabeled antigen was prepared as described for the labeled 
antigen from decapitated and eviscerated chick embryos. 
Equilibrium Gel Filtration Assay for Macromolecular Asso- 
ciations:  Gel filtration was routinely performed on  an  Ultrogel  AcA22 
(LKB, Gaithersburg, MD) column with a bed volume of 0.2  x  30 cm. 60-ul 
fractions  were  collected  at a  flow rate of 0.7  ml/h. The  void and included 
volumes of this column were 0.54 and  1.5 ml, respectively. For fractionation 
of larger volumes a  l  x  12-cm bed volume was used which had void and 
included volumes of 3.5 and 13 ml, respectively,  l-ml fractions were collected 
at a  flow rate of 5 ml/h. Ultrogel AeA22 has a  linear fractionation range of 
100,000-1,200,000  D. 
When interactions between  either fibronectin or laminin with the antigen 
were studied,  a void volume equivalent of ligand in 0.01 M Tris-HAc,  0.5% 
Nonidet P-40, 0.15  M NaCI, 0.5 mM CaCl2 at pH 8 (TNC) was first run into 
the column. The mixture of 35S-labeled antigen and ligand was then added to 
the column followed  by a  void volume equivalent of ligand in TNC.  Two 
specific activities of antigen were used:  2.2  x  l0  s mCi/mmol and 43  mCi/ 
mmoL The column was eluted further with TNC alone. Thus throughout its 
journey in the column the antigen saw a roughly constant, high concentration 
ofligand. This was done to ensure continued receptor occupancy in the case of 
rapid ligand-receptor equilibria. In concept,  this technique is reminiscent of 
that described by Hummel and Dryer (19). However there are significant  and 
noteworthy differences. 
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estimated using linearizations of the following expression: 
L(I -0)  K¢ 
where 0 is the fraction of occupied receptors, L is the ligand concentration,  and 
Kd is the dissociation constant of the antigen-ligand  complex. 
The synthetic  tetramer  (arg-gly-asp-ser), hexamer (gly-arg-gly-glu-ser-pro), 
and decamer  (arg-gly-asp-ser-pro-ala-ser-ser-lys-pro)  were obtained  from Pen- 
insula Laboratories, Inc., Belmont, CA; the synthetic nonamer (arg-lys-lys-thr- 
gly-gin-glu-ala-cys) was a  gift from Jeremy  Paul  and  Richard  Hynes.  The 
affinities of the  nonamer and tetramer for the antigen  were estimated  from 
their inhibition of  fibronectin or laminin binding using the following expression: 
IGO1 
Ki 
L  -  OL  -  oKa' 
where I  is the  peptide  concentration,  and Ki is the inhibition  (dissociation) 
constant for the peptide-antigen  complex. 
For antigen and laminin  binding, the  fractional occupancy  was estimated 
by integrating the areas under the peaks in the elution profiles representing the 
antigen  and antigen-antibody  complexes,  respectively. The fractional  occu- 
pancy for the fibronectin  interaction  was estimated  by decomposing the peak 
in the elution  profile into components arising from the antigen-fibronectin 
complex (peak shoulder) and the antigen alone and by estimating the fractional 
peak shift. The binding  constants  derived  from the fibronectin  data,  due to 
their  complex  nature,  provide  only  an  order  of magnitude  estimate.  The 
inhibition constants for the peptides were determined by measuring the fraction 
of occupied  receptors in the presence of a constant  400 #g/ml of laminin  or 
fibronectin and varying concentrations  of the peptide. The estimates of recep- 
tor-ligand  equilibria  provided  by this method should  only be considered  as 
first approximations.  Possible receptor and ligand aggregation, micellar inter- 
actions  of the  antigen,  and details  of the column elution  phenomena were 
ignored in making them. 
Determination of Hydrodynamic Parameters:  Sedimentation 
of the CSAT antigen  in sucrose gradients  were performed  and analyzed  as 
described elsewhere (20-22). Linear density gradients from 5-20% sucrose were 
poured into 5-ml cellulose nitrate ultracentrifuge tubes. The sucrose solutions 
were buffered in TNC (without  NaCl) at pH 8. The gradients were overlaid 
with  100 #l of TNC containing  labeled antigen  and calibrating  enzymes (#- 
galactosidase 15.93 S, 25 #g/ml;  catalase 11.3 S,  100 #g/ml;  fumarase 9.09 S, 
50 #g/ml; lactic dehydrogenase 6.95 S, 30 #g/ml; and cytochrome c 1.71 S, 2 
mg/ml) (Sigma Chemical  Co.). The tubes were spun in a  Beckman  SW 60 
rotor (Beckman Instruments, Inc., Palo Alto, CA) at 45,000 g for 9 h at 4"C. 
Fractions  containing  roughly  150 ul were collected. The calibrating enzymes 
were assayed spectrophotometricaUy.  The sedimentation  coefficient  for the 
antigen was determined  graphically by comparing  it with that of calibrating 
enzymes or by use of the sedimentation  equation. 
The Stokes radius for the antigen was determined by comparing its elution 
profile from an Ultrogel AcA22 (LKB) column with that of  calibrating enzymes: 
thyroglobin (8.5 nm), ferritin (6.1 nm), catalase (5.22 nm), and aldolase (4.81 
nm) (High Molecular Weight Standard Kit, Pharmacia  Fine Chemicals, Pisca- 
taway, N  J). The labeled antigen and calibrating  enzymes were run in TNC 
buffer (without  NaC1) at a flow rate of 5 ml/h. (The presence or absence of 
NaCI did not affect the elution profiles.) 
The  molecular  weight and frictional coefficient for the detergent-antigen 
complex was calculated from the above gel filtration and sedimentation  data 
as described by Clarke (20). The detergent contribution  to the molecular weight 
was estimated using a value of 0.948 g/ml and 0.735 g/ml for the partial molar 
volumes of the detergent (23) and antigen (20), respectively. 
RESU LTS 
Effect of CSAF Monoclonal Antibody on Spread 
Cells Adhering to Defined Substrata 
When chick embryo tendon or cardiac fibroblasts from cell 
cultures were removed with EDTA and added to tissue culture 
dishes coated with either fibronectin or laminin, the majority 
of cells spread and assumed fibroblast-like morphologies. On 
fibronectin 90%  of the tendon fibroblasts were spread after 
30  min, whereas the cardiac fibroblasts plated with a lower 
efficiency and required slightly longer times, 40-60  min,  to 
spread.  The rate of adhesion of both types of fibroblasts to 
laminin was slower than to fibronectin by 30-60  min; how- 
ever, by 2  h  nearly all of the attached ceils had spread and 
assumed a  fibroblast-like morphology on either substratum. 
The adhesion of skeletal myoblasts to these substrata also was 
investigated.  On  the  former  substratum  most  of the  cells 
assumed a bipolar morphology, whereas on the latter they are 
more fibroblast-like (Fig.  1).  Comparable effects for all cell 
types and substrata were obtained using either tissue culture 
or nontissue culture wells. The nontissue culture wells did not 
promote any cell attachment in the absence of added substrate 
material. Uncoated tissue culture wells support only a modest 
FIGURE  1  Effect of CSAT  mono- 
clonal  antibody  on  adhesion  of 
cardiac fibroblasts to laminin and 
fibronectin.  Cardiac  fibroblasts, 
pretreated for 2  h  with  25 #g/ml 
cycloheximide, were plated in cy- 
cloheximide  containing  serum- 
free  DME  onto  wells  (200  mm  2) 
coated with  either fibronectin  or 
laminin at a density of 1.25 x  10  s 
cells/well. The cells were allowed 
to adhere and spread for 2 h. The 
CSAT  monoclonal  antibody  was 
then added at a concentration of 
40 #g/ml. The cultures were pho- 
tographed 2  h  after antibody ad- 
dition. Bar, 40 ~m. 
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clonal  antibody  on  adhesion  of 
skeletal myoblasts to laminin and 
fibronectin.  Skeletal  myoblasts 
were  plated  on  laminin  or  fibro- 
nectin-coated  dishes  (35  ram)  in 
DME containing 10% horse serum 
at  a  density  of  3.5  x  10  s  cells/ 
dish. The CSAT monoclonal  anti- 
body (20 #g/ml) was added at the 
time of plating. The cultures were 
observed  48  h  after  plating.  Bar, 
40 p.m. 
attachment under the conditions of these assays. The time 
course of this adhesion is considerably slower (two to three 
times) than on wells coated with either fibronectin or laminin. 
Finally when the CSAT monoclonal antibody itself was used 
to coat the wells, cells adhered and spread. This was unique 
among several antibodies tested and suggests  that the CSAT 
antibody can serve as an adhesion-promoting ligand. 
Addition  of the  CSAT  monoclonal  antibody  to  tendon 
fibroblasts, allowed first to adhere and spread on laminin for 
1-2 h, induced the rounding of nearly all the cells (Table I). 
In contrast, the CSAT monoclonal antibody added to tendon 
fibroblasts after prior plating on fibronectin caused a  retrac- 
tion of their edges and rounding of only 20-30% of the cells. 
The response of the skeletal myoblasts to the CSAT monoclo- 
nal antibody was analogous to that of the tendon fibroblasts. 
Cardiac  fibroblasts,  on  the  other  hand,  when  plated  and 
allowed to spread on either substratum, were not detectably 
affected by the CSAT monoclonal antibody. Cardiac fibro- 
blasts, first preincubated with cycloheximide (25 ~g/ml for 2 
h), plated onto a laminin coated dish, and allowed to adhere 
and spread for 2 h, could now be rounded and detached by 
addition  of the  CSAT  monoclonal antibody (Fig.  2).  This 
suggests  that  cardiac  fibroblasts  synthesize  molecules  that 
mediate adhesions in which the CSAT antigen does partici- 
pate. Tendon and cardiac fibroblasts, allowed to adhere and 
spread on  poly-L-lysine for 2  h,  were not  detached  by the 
antibody lending specificity to our results. 
Effect of the CSAT Monoclonal Antibody on 
Initial Adhesive Events 
The observations just presented address the effects of the 
CSAT monoclonal antibody on the adhesion and morphology 
of cells  that  had  already  adhered  and  spread  on  defined 
substrata. We have also studied the effects of the antibody on 
initial adhesive events that occur before extensive organiza- 
tion of adhesion plaques and the cytoskeletal apparatus. We 
TABLE  I.  Summary of Effects of CSAT Monoclonal Antibody on Cell 
Adhesion  and Morphology on Either Fibronectin or Laminin 
Cell type 
Laminin  Fibronectin 
Initial  Initial 
adhe-  Mor-  adhe-  Mor- 
sion  phology  sion  phology 
Cardiac fibroblast  +  -  -  - 
Cyclohex-cardiac fibro-  +  +  -  - 
blast 
Tryp-cardiac fibroblast  NA  NA  +  - 
Tendon fibroblast  +  +  +  p 
Cyclohex-tendon  fibro-  +  +  +  p 
blast 
Tryp-tendon fibroblast  NA  NA  +  p 
Skeletal myoblast  +  +  +  p 
Morphology, CSAT monoclonal antibody added after ceils have adhered and 
spread for 30-180 rain.  Initial adhesion, CSAT monodonal antibody added 
at the time of plating. +, rounded and detached cells when added to spread 
cells and inhibits initial adhesion when added at the time of plating.  -,  no 
detectable effect,  p, partial effect;  caused a retraction of edges and rounding 
of only some cells  when added to spread  cells  and inhibited adhesion of 
only some cells  when added at the time of plating.  NA, no adhesion; the 
cells do not adhere under these conditions. Cyclohex-cardiac and cyclohex- 
tendon fibroblast, tendon and cardiac fibroblasts preincubated with 25 pg/ 
ml cycloheximide for 2  h  before  harvesting.  Tryp-cardiac and tryp-tendon 
fibroblast, tendon and cardiac fibroblasts  preincubated for 2 h with 25 pgJml 
cycloheximide and then treated with  !  mg/ml trypsin for 20-30 rain.  Cells 
were plated onto wells in DME containing the CSAT monoclonal antibody 
and incubated for 30-180 min  (initial  adhesion).  The cultures were scored 
visually for the relative fraction of adherent cells.  For some experiments the 
cells were allowed to first  adhere and spread for 30-180 min (morphology) 
before additions. These cultures  were generally scored 60 rain subsequently. 
have developed a quantitative assay, based on that described 
by McClay et al. (18), to measure the relative adhesive strength 
of cells to defined substrata. In this assay cells are centrifuged 
onto the bottom of a well, allowed to incubate, and then the 
wells are inverted, and the weakly adherent cells removed by 
centrifugation. The key variables are the choice of molecules 
used to coat the wells, the incubation time and temperature, 
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weakly adherent cells. 
The fraction of  cells remaining adherent was measured after 
different incubation times using an RCF of 66 g, the highest 
force assayed. The adhesion of tendon and cardiac fibroblasts 
reached a plateau after ~30-45 min and 45-60 min, respec- 
tively, at which time 50-80%  of the cells had adhered. For 
both cell types the kinetics of adhesion to either fibronectin 
or  laminin  were  similar;  however,  fewer  cells  adhered  to 
laminin than to a fibronectin-coated substratum. In general 
fewer cardiac fibroblasts adhered than did tendon fibroblasts. 
This likely reflects the lower plating efficiency and viability of 
the cardiac fibroblasts. 
The fraction of  cells remaining adherent after centrifugation 
at three different RCFs,  1 g (1.2 x  10  -7 dynes),  13 g (1.6 x 
10  -6 dynes), and 66 g(8 x  10  -6 dynes), is presented in Fig. 3. 
Adhesion of  both tendon and cardiac fibroblasts to fibronectin 
showed a steady decrease in the fraction of adhering cells with 
increasing  RCF.  The  shapes of the  curves for laminin,  in 
contrast, showed little variation with g-force between 1-13 g 
after which the fraction of cells remaining adherent decreases. 
The effect of the CSAT monoclonal antibody on the adhe- 
sion of both cell types to wells coated with either laminin or 
fibronectin was studied using this assay (Figs.  3 and 4). The 
presence of the CSAT monoclonal antibody at the time of 
plating inhibited  the  adhesion  of the  tendon  fibroblasts to 
both substrata. Adhesion to laminin was inhibited essentially 
completely (>10-fold)  at  all  RCFs  assayed  including  1 g, 
whereas adhesion to fibronectin was inhibited only partially 
(2-3-fold) at the same RCFs. In contrast to the effects of the 
CSAT monoclonal antibody on the adhesion of tendon fibro- 
blasts,  the  antibody  inhibited  only  minimally (<25%)  the 
adhesion of the cardiac fibroblasts to fibronectin (Fig. 4). This 
small difference, though within experimental error, was seen 
in all experimental pairs. As described  for the adhesion of 
tendon  fibroblasts to laminin,  the CSAT monoclonal anti- 
body  inhibited  essentially  completely  adhesion  of cardiac  I:A 
cO 
lOO 
80 
60 
40 
20 
B 
i,,_ 
FN  FN  LM  LM 
+  + 
CSAT  CSAT 
F=GURE  3  Initial  adhesion  of 
tendon  (A) and cardiac (B) fi- 
broblasts  to  fibronectin  and 
laminin  substrata.  48-h  cul- 
tures  were  harvested  with 
EDTA  and  centrifuged  onto 
multiwells coated with  either 
laminin or fibronectin at a con- 
centration  of  6  /~g/cm 2.  The 
wells were  incubated  for  30 
min (tendon fibroblasts) or 45 
rain  (cardiac  fibroblasts)  at 
37°C, the wells were inverted, 
the  weakly  adherent  cells 
were sedimented at 66 g, and 
the  remaining  cells  were 
counted.  The  percentage  of 
cells attached are the number 
of cells remaining adherent di- 
vided by the number of cells 
added to the wells, times 100. 
CSAT  monoclonal  antibody 
was added at a concentration 
of 20/~g/ml at the time of plat- 
ing.  FN,  fibronectin-coated 
wells;  LM,  laminin-coated 
wells. 
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FIGURE  4  Relative adhesive strength of tendon and cardiac fibro- 
blasts  plated  on  fibronectin  (A)  and  laminin  (B).  Adhesion  was 
assayed as described in the legend to Fig. 3 except that the weakly 
adherent cells were sedimented at either  1 g,  13 g, or 66 g. The 
data are the averages of at least two separate determinations. The 
error bars are omitted for clarity. (@) Tendon fibroblasts; (11) tendon 
fibroblasts with CSAT monoclonal antibody; (O) cardiac fibroblasts; 
(I-1) cardiac fibroblasts with CSAT monoclonal antibody. 
fibroblasts to laminin. When  CSAT inhibition experiments 
were done using uncoated wells not treated for tissue culture, 
the fraction of cells remaining on the dish remained at the 
null value seen on these wells without antibody. 
The response to the CSAT monoclonal antibody and the 
force-adhesion data for tendon and cardiac fibroblasts binding 
to laminin are readily interpreted as arising from an essentially 
homogeneous population of cells  possessing a  single  (or at 
least a very dominant), CSAT monoclonal antibody sensitive 
adhesion mechanism for laminin. The adhesion to fibronectin 
appears more complex. The fractional inhibitions of tendon 
fibroblast adhesion,  at all RCFs,  by the CSAT monoclonal 
antibody suggests heterogeneity in the cell population. Adhe- 
sive heterogeneities among cells in a population could arise 
from different numbers of receptors per cell,  variations in 
their interactions, or intrinsic heterogeneity of the cell types 
in the population. In any case our observation that the initial 
adhesion  on  fibronectin  of some  cells  is  inhibited  by the 
CSAT  monoclonal  antibody,  e.g.,  the  tendon  fibroblasts, 
while the adhesion of others is not, e.g., the cardiac fibroblasts, 
suggests the presence of CSAT sensitive and insensitive adhe- 
sion mechanisms to fibronectin. 
Additional experiments were performed to characterize fur- 
ther the adhesion of these cells. In one the cardiac and tendon 
flbroblasts were pre-incubated for 3-5 h with cycloheximide 
to inhibit protein synthesis; in another,  cytochalasin b  was 
used to inhibit cell  spreading and cytoskeletal organization. 
With either treatment, the effects of the CSAT monoclonal 
antibody on the adhesion of the two cell types to laminin and 
fibronectin remained similar to those just described for cells 
without these treatments. In contrast, pre-incubating the fi- 
broblasts with trypsin altered some adhesive properties. This 
was explored by plating cells, first incubated with cyclohexi- 
mide  and  subsequently  digested  with  1  mg/ml  trypsin  in 
HEPES-Hanks buffer for 20-30 rain (24), onto coated wells, 
incubating  the  wells  for  30-120  rain,  gently  pipetting  to 
remove the nonadherent cells, and scoring the fraction of cells 
remaining on the dish. 2 The adhesion of trypsin-treated car- 
E  Skeletal myoblasts were unique  in  that  the  CSAT monoclonal 
antibody delayed their attachment to both laminin and fibronectin 
for long periods of time (at least 48 h) even in serum-supplemented 
cultures. diac  fibroblasts to  fibronectin  was  inhibited  by the  CSAT 
monoclonal antibody (Table I). In the absence of antibody 
most of the trypsin-treated cells attach and spread after an 
hour  in  culture.  In the  presence of antibody,  only  ~40% 
attach.  The CSAT monoclonal antibody did not detectably 
affect trypsin-treated cells that had been allowed to first adhere 
and spread. Neither tendon nor cardiac fibroblast adhered to 
laminin after the cycloheximide plus trypsin treatments. 
The adhesion of these cells to some other substrata was also 
investigated using this assay. The initial adhesion of cardiac 
and tendon fibroblasts to poly-L-lysine was not inhibited by 
the CSAT monoclonal antibody, whereas adhesion of tendon 
fibroblasts to both type I and type IV collagen was inhibited 
completely by the antibody. The antibody partially inhibited 
adhesion to vitronectin. 
Interactions  between the Purified CSA T Antigen 
and Extracellular Ligands 
The  above observations implicate  the  CSAT  antigen  in 
adhesion to both laminin and fibronectin. We have explored 
the possibility that it functions as a  receptor for these sub- 
strates by assaying for interactions between the purified anti- 
gen and these putative iigands. Most assays for associations 
of integral membrane components with cytoskeletal or extra- 
cellular components rely on relatively high affinities. Raising 
the effective valency by presenting the protein in liposomes 
or coupled to an inert support is one way to circumvent this 
problem and assay for weak or rapidly exchanging interac- 
tions. Another approach is to use separation techniques that 
can be performed in the continued presence of high concen- 
trations  of one  of the  constituents.  This  ensures  receptor 
occupancy even in the presence of rapid equilibria. We have 
chosen  this  latter  approach  using  a  gel  filtration  column 
(Ultrogel AcA22) that is preloaded with ligand at the concen- 
tration to be assayed. Thus in this experiment the antigen, as 
it passes through the column, is exposed to a roughly uniform 
ligand concentration. This equilibrium gel filtration method 
also  provides estimates of antigen-ligand  dissociation  con- 
stants from measurements of the fraction of antigen in the 
ligand receptor complex (slow exchange) or the fractional shift 
of the peak representing the complex (fast exchange). 
Fig.  5A  shows the elution profile of detergent-solubilized 
antigen. As a positive control, the elution profile of antigen 
in  the  presence of the  CSAT  monoclonal antibody is also 
shown. The presence of the antibody produced a shift in the 
elution profile of the antigen toward the void volume. This 
shift is expected from an antigen-antibody complex which 
would have a  larger effective Stokes radius than that of the 
antigen alone. The shift did not require pre-equilibration of 
the column with antibody. The elution profiles were studied 
over an antibody concentration range of 0.1-20 #g/ml. A/G 
of 6 x  10  -9 M (Table II) was estimated from linearizations of 
the binding data. This affinity compared well with that mea- 
sured for CSAT monoclonal antibody binding to whole cells 
(6 x  10  -9 M) (5). 
Fig.  5 B  shows the effect of pre-equilibrating the column 
with laminin on the elution profile of the CSAT antigen. An 
additional peak that migrates in the void volume appears at 
a laminin concentration of 50/~g/ml.  3 The presence of this 
3  The peak at the void volume was not apparent unless the column 
was pre-loaded with laminin; when the peak fractions were isolated 
and rerun without preloading the column, the complex was no longer 
extra peak reveals an association  between  the  antigen  and 
laminin.  The  fraction  of antigen  migrating in  this  region 
increased  as  the  laminin  concentration  increased  and  was 
linear, over the concentration range studied, i.e.,  25-400 ~g/ 
ml, on Eadie-Hofstee or double reciprocal plots (25). The K~ 
extrapolated from these representations was 2 x  10  -6 M. An 
analysis of the material in the void volume peak using SDS 
PAGE showed the same three bands that are present in the 
original antigen (Fig. 6). Prior incubation of the antigen with 
CSAT antibody blocked the formation of the extra peak in 
the void volume (Fig.  5 C). The CSAT monoclonal antibody 
concentration  required for this effect was the same as that 
required to form the antigen-antibody complex as shown in 
Fig. 5A. 
An analogous series of measurements were made using a 
column preloaded with fibronectin rather than laminin.  At 
fibronectin concentrations above 50 #g/ml, the dution profile 
of the antigen appeared shifted toward higher excluded vol- 
ume, and a prominent shoulder appeared on the void volume 
side of the peak (Fig.  7A). The presence of this shifted peak 
and shoulder reveals an interaction between the antigen and 
fibronectin. The magnitude of this effect increased over the 
limited  fibronectin  concentration  range  studied--100-400 
#g/ml. These data, due to the overlap between the antigen- 
fibronectin complex and the original antigen, provided only 
a very rough estimate of 10  -6 M for the Kd of this interaction. 
SDS PAGE of the material in the shoulder shows the same 
three  bands  as in  the  native antigen.  The position  of this 
shoulder was  very similar to  that  of the  antigen-antibody 
complex.  This  complicates  demonstrating  that  the  CSAT 
antibody inhibits  this  interaction.  We  have  taken  another 
approach to ascertaining the significance of this interaction 
by using a tetrapeptide (arg-gly-asp-ser) reported to represent 
the cell binding domain of fibronectin (26, 27). This peptide, 
when  included  with  the  fibronectin  in  the  usual  protocol, 
inhibited formation of the shoulder assigned to the fibronec- 
tin-antigen complex (Fig. 7 B). The inhibition occurred in the 
concentration  range of 10-100  #g/ml.  The inhibition  data 
were used to estimate a Ki of 10-3-10  -4 M for the tetrapeptide 
inhibition of the fibronectin-antigen interaction. A decapep- 
tide (arg-gly-asp-ser-pro-ala-ser-ser-lys-pro)  containing the cell 
binding peptide sequence also inhibited the formation of the 
complex (not shown). These same peptides were used in the 
laminin experiments and were found to inhibit the interaction 
of laminin with the CSAT antigen as well (Fig.  5 D). When 
the column was preloaded with both fibronectin and laminin, 
the elution profile showed both the shoulder characteristic of 
the  fibronectin-antigen interaction and a  peak in  the void 
volume characteristic of  the laminin-antigen interaction. This 
result along with the  inhibition  of the antigen  interactions 
with both fibronectin and laminin by the cell binding tetra- 
peptide from fibronectin suggest that laminin and fibronectin 
are binding to neighboring or sterically related sites. 
These interactions appear to be both meaningful and sig- 
nificant.  An  unrelated  antibody  that  inhibits  adhesion  to 
substrata other than  fibronectin  and  laminin  (unpublished 
present. The presence of a resolvable peak for the  antigen-ligand 
complex suggests that the exchange rate of the antigen-ligand com- 
plex is slow on the time scale of  the gel filtration experiment. Whereas 
this may be the intrinsic nature of the interaction, it may also arise 
from antigen binding to a laminin  aggregate whose formation  is 
concentration dependent. 
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hGURE  5  Equilibrium gel filtration elution profile of CSAT antigen 
from columns pre-equilibrated with the CSAT monodonal antibody 
(A),  laminin (B), CSAT  monocIonal  antibody and  laminin (C), or 
fibronectin  peptide  analogue and  laminin (D).  Gel  filtration was 
performed using Ultrogel AcA22 with TNC buffer containing 0.1% 
Nonidet  P-40. The column was  first  preloaded  with the  desired 
ligand, and 35S-labeled CSAT antigen (with cold  ligand)  was then 
run through the  column.  60-#1 fractions were collected  and  the 
labeled antigen counted. Vo is the void volume, and VT iS the total 
included volume. (A) (O) antigen alone; fiE) antigen passed through 
column  pre-equilibrated with 10 #g/ml  CSAT antibody. (B) CSAT 
antigen passed through column pre-equilibrated with: (L~) 2.5 #g/ml 
laminin, (@) 100 p.g/ml laminin, (l) 200 p.g/ml laminin; (O) 400 #g/ 
ml  [aminin.  (C)  ((3) CSAT  antigen  passed through  column  pre- 
equilibrated with 400 p.g/ml laminin; (l) CSAT antigen first prein- 
cubated with 20 p.g/ml CSAT monoclonal antibody and then passed 
through column pre-equilibrated with 400/zg/ml laminin. (D) CSAT 
antigen passed through the column pre-equilibrated with: (@) 400 
#g/ml laminin and I  mg/ml cell binding tetrapeptide; (r-l) 400 #g/ml 
laminin and I  mg/ml nonapeptide. 
observations) does not inhibit formation of  the ligand-antigen 
complexes. Two synthetic peptides that do  not  inhibit  cell 
adhesion,  a  nonapeptide  (arg-lys-lys-thr-gly-gln-glu-ala-cys) 
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FIGURE 6  SDS PAGE of CSAT antigen and CSAT antigen-laminin 
complexes. Gel filtration was performed as described in Fig. 5 (with 
the  column  pre-equilibrated  with  400  /~g/ml laminin).  The void 
volume  fraction  corresponding  to  the  antigen-laminin complex 
(fraction 9) (A), the fractions corresponding to free antigen (fractions 
14-16), and (B) an aliquot of CSAT antigen before gel filtration (C) 
were run on 7% nonreducing SDS PAGE and visualized by autora- 
diography. 
from a region of fibronectin that does contain the cell binding 
sequence and a bexapeptide (gly-arg-gly-glu-ser-pro)  contain- 
ing a single substitution in the cell binding region (27),  had 
no effect on the formation of  either the laminin or fibronectin 
complexes (Figs. 5 and 7). Pre-equilibrating the column with 
400  ug/ml  BSA  did  not  alter  the  antigen  elution  profile. 
Finally, the presence of 400 ~g/ml fibronectin or laminin did 
not alter the elution of catalase, a Stokes radius standard. 
The unexpected observation that the fibronectin cell-bind- 
ing tetrapeptide inhibits the interaction of the purified CSAT 
antigen with both laminin and fibronectin prompted a prelim- 
inary examination of its significance by assaying for the effect 
of this peptide on cell adhesion to wells coated with these two 
substrata.  Fig.  8  shows  that  the  tetrapeptide  but  not  the 
hexapeptide (or nonapeptide) inhibited  adhesion  of tendon 
fibroblasts to fibronectin. We also observed similar effects of 
these peptides on the adhesion of the cardiac fibroblasts on 
fibronectin. These specificities confirm the previous observa- 
tions by others (26,  27).  The effect of the tetrapeptide and 
hexapeptide on adhesion of tendon fibroblasts to laminin is 
also shown in Fig.  8. A  partial inhibition was observed but 
appeared significant when compared with the hexapeptide (or 
nonapeptide) control, which did not show comparable effects 
even at 3-5-fold higher concentrations. The cell binding tetra- 
peptide showed only a  vei-y small effect on the adhesion of 
the cardiac fibroblasts to laminin. A  more thorough exami- 
nation of specificities will  be required before these observa- 
tions are fully understood. A 
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FIGURE  7  Equilibrium gel filtration elution profile of CSAT antigen 
from a column pre-equilibrated with fibronectin (A) or fibronectin 
and cell binding tetrapeptide from fibronectin (B}. Gel filtration was 
performed as described in the legend to Fig. 5. (A) (I-I} CSAT antigen 
alone; {O)  CSAT antigen passed through column  pre-equilibrated 
with  200/~g/ml  fibronectin.  (B) (@) CSAT antigen passed through 
column  pre-equilibrated with 200 ~.g/ml fibronectin  and  1 mg/ml 
cell binding tetrapeptide; (A) CSAT antigen passed through column 
pre-equilibrated with 200/~g/ml fibronectin and 1 mg/ml fibronectin 
9-mer. 
The Oligomeric Nature of the CSA T Antigen 
Complex 
The  presence  of all  three  glycoproteins comprising  the 
CSAT antigen in the CSAT antigen-laminin and CSAT an- 
tigen-fibronectin  complexes  raises  the  possibility  that  the 
antigen itself is an oligomeric complex. We have explored this 
by studying the behavior of the antigen during gel filtration 
and velocity sedimentation in sucrose density gradients. As 
reported above, the antigen elutes as a single peak on Ultrogel 
AcA22, a molecular sieve. Subfractions from the leading and 
trailing edges and the center of the peak were analyzed by 
SDS  PAGE.  The  gel  profiles  from  the  subfractions  were 
indistinguishable  and revealed the same three bands in the 
proportions seen in the  unfractionated antigen.  The CSAT 
antigen was also studied by sedimentation velocity in 5-20% 
linear sucrose gradients. The antigen resolved into a  major 
peak and a  small minor peak. Both were analyzed on SDS 
PAGE  (Fig.  9).  The antigen  present in  subfractions of the 
leading and trailing edges and center of the major peak were 
TABLE II.  Binding Equilibria of CSAT  Antigen with Different Ligands 
Ligand  Kd  K~ 
M 
CSAT antibody  6 x  10  -9  -- 
Laminin  2 x  I0  -°  -- 
Fibronectin  10  -6  -- 
Tetrapeptide (inhibition of laminin  --  2 x  10  -4 
binding) 
Tetrapeptide (inhibition of fibronectin  --  10  -3-10  -4 
binding) 
Nonapeptide (inhibition of laminin  --  >5 x  10  -I 
binding) 
Nonapeptide (inhibition of fibronectin  --  >5 x  10  -1 
binding) 
The binding equilibria for the interaction of the purified CSAT antigen in TNC 
with the CSAT monoclonal  antibody, laminin, and fibronectin were estimated 
using the equilibrium gel filtration method described in the text. The inhibi- 
tion constants were measured from concentrations  required to inhibit inter- 
action of the purified antigen with fibronectin or laminin. 
indistinguishable  from  each  other  and  revealed  the  three 
bands characteristic of the original antigen. The minor peak 
contained only a single component that migrated like band 3 
on SDS PAGE. Purified band 3 also migrated in this position 
(Buck,  C.,  and  A.  Horwitz,  unpublished  observation).  Al- 
though  the  origin  and  significance of this  satellite peak is 
unclear, its presence demonstrates that the gradient can re- 
solve and  separate monomers from oligomers.  These  data 
together with our previous observations that the three bands 
comprising the CSAT antigen tend to co-purify using several 
different kinds of purification  procedures suggests  that the 
antigen resides as an oligomer (7). 
The gradient and gel filtration data were used to estimate 
the sedimentation coefficient, Stokes radius, and molecular 
weight of the oligomeric complex (20-22):  S,,2o =  8.6;  a  = 
6.0 rim; and tool wt =  235 kD (detergent + antigen) and 212 
kD (antigen alone), respectively. 
DISCUSSION 
In previous studies we have shown that the CSAT antigen 
participates in the adhesion of several different kinds of cells 
to extracellular matrices and that not all cell types respond 
similarly to the  CSAT monoclonal antibody.  We have ex- 
tended these observations by addressing three related issues: 
the extracellular molecules with which adhesions involving 
the CSAT antigen might interact; the role played by the CSAT 
antigen in the adhesion process; and the origin of the different 
responses to the  CSAT monoclonal antibody displayed by 
different cell types. 
The effect of  the CSAT monoclonal antibody on fibroblasts 
and myoblasts plated on laminin demonstrates that the anti- 
gen participates in their adhesion to this extracellular mole- 
cule.  Short term cultures of skeletal myoblasts and cardiac 
and tendon fibroblasts plated on laminin-coated dishes round 
and detach from the substratum when the CSAT monoclonal 
antibody is added. This effect of the CSAT monoclonal anti- 
body is seen with well spread cells as well as with cells in 
earlier stages of adhesion. The observation that the residual 
adhesive strength of cells treated with the CSAT monoclonal 
antibody does not withstand a  force of l  g  (10  -7 dynes) is 
particularly important. It demonstrates that the antigen plays 
a very dominant role in the adhesion of these cells to laminin. 
Other adhesive interactions,  if they were to exist,  must be 
very weak or involve only a few molecules. Recent observa- 
HORWITZ ET AL.  A Laminin  and fibronectin  Receptor  2141 FIGURE  8  Effect of fibronectin  peptides on adhesion of tendon fibroblasts. Tendon fibroblasts were plated in serum-free DME 
onto laminin- or fibronectin-coated wells (200 mm  2) in  10-#1 spots at a density of 4  x  105 cells/ml. The peptides were added at 
the time of plating at a concentration of 1 mglml (tetrapeptide) and 1.6 mg/ml (hexapeptide). The cultures were flooded after 2 
h of incubation and then photographed. Bar, 40 #m. 
hGure  9  SDS  PAGE  analysis of CSAT  antigen in  fractions  from 
sucrose density gradients. 35S-labeled  antigen in TNC was layered 
onto a 5-20% sucrose density gradient and sedimented for 8-9  h 
at  45,000  rpm  at  4°C  in  a  SW60  rotor.  150-~1 fractions  were 
collected. The first fraction corresponds to the bottom of the tube. 
The  material in  the  main  peak (fractions  t 1-16)  and  minor peak 
(fractions  19-32)  were  pooled  separately and  analyzed  on  SDS 
PAGE  run under nonreducing condition. The left and right profile 
in the insert correspond to the main and minor peaks, respectively. 
tions on the localization of the antigen are consistent with its 
role  in  adhesion  to  laminin.  The  antigen  co-localizes with 
laminin  in  regions  of acetylcholine  receptor  hot  spots  on 
cultured  myotubes (Bozyczko, D.,  and A.  Horwitz, unpub- 
lished observations). These are thought to be sites of interac- 
tion  between  the  basal  lamina,  the  cell  surface,  and  the 
cytoskeleton (28, 29). 
The observations reported here also implicate the  CSAT 
antigen in adhesion to fibronectin. The adhesion of  the tendon 
fibroblasts and skeletal myoblasts is inhibited substantially by 
the  presence of the  CSAT  monoclonal antibody.  Although 
the adhesion of the cardiac fibroblasts is not inhibited signif- 
icantly by the CSAT monoclonal antibody, prior treatment 
with trypsin in the presence of calcium renders their adhesion 
sensitive to the antibody. The total inhibitions of adhesion by 
the CSAT monoclonal antibody seen for cells on laminin was 
not observed for cells on fibronectin. This observation along 
with the minimal effects of the CSAT monoclonal antibody 
on cardiac fibroblasts point to differences between adhesion 
to fibronectin and laminin. Morphological studies also impli- 
cate the CSAT antigen in adhesion to fibronectin. On fibro- 
blasts, the CSAT antigen co-localizes with fibronectin along 
portions of stress fibers, at the cell periphery, and in regions 
surrounding the focal contact as visualized by vinculin stain- 
ing (5,  8). Other investigators, using the JG-22 monoclonal 
antibody that is directed against the same antigen, have also 
localized  the  antigen  to  fibronectin-rich  adhesion  sites  on 
fibroblasts (11,  11 a). 
The  question  arises  concerning  the  role  that  the  CSAT 
antigen plays in adhesion to these matrix molecules (30). Two 
obvious hypotheses are that (a)  it functions as a  structural 
molecule to organize the adhesion complex or (b) it functions 
directly  in  adhesion  as  a  receptor for  extracellular  matrix 
ligands. We have explored the latter hypothesis--that it func- 
tions as their cell surface receptor. Our observation that the 
purified antigen interacts with laminin and fibronectin pro- 
vides direct evidence supporting this hypothesis. It is strength- 
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antibody and the cell-binding peptides from fibronectin on 
formation  of the  antigen-laminin  and  antigen-fibronectin 
complexes, respectively. The  /G  for the  interaction  of the 
antibody with the purified antigen and the antibody concen- 
trations required for inhibition of the antigen-laminin com- 
plex are identical with those reported previously for the dis- 
sociation constant for the antibody binding to antigen on cell 
surfaces and for inhibition of cell adhesion by the antibody 
(5).  Yamada and co-workers (31,  32) have investigated the 
binding  of fibronectin  and  its  fragments to  baby hamster 
kidney fibroblasts. They report that the receptor is resistant 
to trypsin in the presence of calcium. They also report 5 x 
10  S fibronectin binding sites per cell with a Kd of 8 x  10  -7 M 
and a Ki of 10-3-10  -4 M  for tetrapeptide inhibition of adhe- 
sion to fibroblasts. Despite the differences in  species,  these 
data are very similar to those that we have estimated for the 
CSAT antigen. We find 5 x  105 CSAT monoclonal antibody 
binding  sites per  fibroblast and  a  Kd  of ~10  -6  M  for the 
antigen-fibronectin interaction. We also find the CSAT-me- 
diated adhesion resists treatment with calcium and trypsin. 
The  observation  that  the  CSAT  antigen  participates  in 
adhesion to both laminin and fibronectin was unexpected but 
of particular  potential  importance.  The  antigen  also  may 
interact with other extracellular ligands and thus may serve 
as a multifunctional extracellular matrix receptor. The inhi- 
bition of antigen interaction with both laminin and fibronec- 
tin by the cell binding tetrapeptide from fibronectin suggests 
that these extraceUular molecules may have a  common se- 
quence  and  all bind  to a  common receptor site.  However 
adhesions to laminin and fibronectin appear to display differ- 
ent  susceptibilities to the CSAT antibody, trypsin, and the 
fibronectin cell-binding tetrapeptide. Therefore, it would seem 
that adhesion to these matrix molecules is more complex than 
the simple interaction of a single receptor binding site with 
its ligands (33).  Hypotheses for the  function  of the  CSAT 
antigen and its interactions with ligands and inhibiting mol- 
ecules must consider the nature of the antigen itself.  It is an 
oligomeric complex composed of  three distinct glycoproteins. 
Where the laminin, fibronectin, and other adhesion-promot- 
ing and inhibiting molecules interact with this complex is a 
problem that remains to be addressed. 
Several papers have implicated proteins migrating in the 
molecular weight range of 140,000  D in adhesion to extracel- 
lular substrates (34-36).  Molecular complexes with average 
molecular weight of 140,000  D  that can block the effect of 
adhesion-perturbing  antibodies  have  been  isolated  from 
mouse and hamster fibroblasts as well as from epithelial cells. 
More recently, Pytela et al. (36) have identified fibronectin- 
binding proteins from human fibroblasts. These proteins, like 
the  CSAT  antigen,  migrate in  the  140-kD  range  on  SDS 
PAGE and resolve into distinct bands when run on nonred- 
uced gels. These proteins further resemble the CSAT antigen 
in that their interaction with fibronectin is competed specifi- 
cally by the tetrapeptide fragment from the cell-binding site 
of fibronectin. 
Three laboratories have described a 67,000-D molecule as 
a  laminin  receptor on  mammalian  muscle,  human  breast 
carcinoma,  and  mouse  melanoma cells (37-40).  Since  the 
CSAT antigen is a complex of three polypeptide chains that 
migrate on reduced SDS PAGE in the molecular weight range 
of 140,000,  it would appear that these putative receptors are 
different. This is also suggested by the higher affinity of the 
mammalian receptor for laminin (41). Lesot et at. (38), how- 
ever, report two bands in the molecular range of 150,000 that 
are recognized by laminin on immunoblots. Recent studies 
on neurite extension using antibodies against different lami- 
nin domains suggest that there may be more than one kind 
of molecule that interacts with laminin (42). In this regard we 
have found that the CSAT antigen is present on nerve and 
have demonstrated its role in  neuron  adhesion and axonal 
extension (43). 
The final issue that we have addressed is why different cell 
types  respond  characteristically  to  the  CSAT  monoclonal 
antibody.  We  have  proposed  elsewhere  that  the  different 
responses reflect a progressive display of additional adhesive 
molecules and their organizational complexes on increasingly 
adhesive cell types (6).  The data reported here extend these 
earlier observations. The inhibition of cardiac fibroblast adhe- 
sion  to  laminin  and  to  fibronectin  demonstrates  that  the 
CSAT antigen  is not only present but  functional on these 
cells. It follows then that they adhere to fibronectin by a more 
complex mechanism than that used on the tendon fibroblasts 
or skeletal myoblasts. An obvious hypothesis is that there is 
more than one kind of mechanism involved in adhesion to 
fibronectin. Recently evidence has been provided for multiple 
fibronectin adhesion mechanisms on neurons (43). 
In summary three lines of evidence argue strongly for the 
CSAT  antigen  functioning  as  a  receptor  for  extracellular 
molecules.  (a)  Monoclonal  antibodies  directed  against  the 
antigen inhibit adhesion to both fibronectin and laminin; (b) 
the antigen localizes in putative regions of cell-matrix adhe- 
sion; and (c) the purified CSAT antigen binds to both fibro- 
nectin  and  laminin  to  form  a  physiologically meaningful 
association. Although only fibronectin and laminin were stud- 
ied in detail, it is likely that CSAT antigen functions more 
generally as a cell surface receptor for extracellular molecules. 
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